Literature DB >> 32243796

A Vaccine against Ebola Virus.

Erica Ollmann Saphire1.   

Abstract

Ervebo is the first licensed vaccine for prevention of Ebola virus disease. The vaccine, originally developed by the Public Health Agency of Canada, is delivered in a single 1 mL dose and has been delivered to >200,000 people in an ongoing 2018-2020 outbreak of disease. To view this Bench to Bedside, open or download the PDF.
Copyright © 2020. Published by Elsevier Inc.

Entities:  

Year:  2020        PMID： 32243796     DOI： 10.1016/j.cell.2020.03.011

Source DB:  PubMed          Journal:  Cell        ISSN： 0092-8674            Impact factor:   41.582


  13 in total

Review 1.  Ebola Virus Disease and Current Therapeutic Strategies: A Review.

Authors:  Kalliopi Io Diakou; Thanasis Mitsis; Katerina Pierouli; Eleni Papakonstantinou; Erik Bongcam-Rudloff; Misaki Wayengera; Dimitrios Vlachakis
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 2.  The use of viral vectors in vaccine development.

Authors:  Tatianna Travieso; Jenny Li; Sneha Mahesh; Juliana Da Fonzeca Redenze E Mello; Maria Blasi
Journal:  NPJ Vaccines       Date:  2022-07-04       Impact factor: 9.399

Review 3.  Advancements in protein nanoparticle vaccine platforms to combat infectious disease.

Authors:  Nina Butkovich; Enya Li; Aaron Ramirez; Amanda M Burkhardt; Szu-Wen Wang
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2020-11-08

4.  Immunization and Drug Metabolizing Enzymes: Focus on Hepatic Cytochrome P450 3A.

Authors:  Kristina Jonsson-Schmunk; Romi Ghose; Maria A Croyle
Journal:  Expert Rev Vaccines       Date:  2021-03-18       Impact factor: 5.217

5.  The sphingosine kinase 1 activator, K6PC-5, attenuates Ebola virus infection.

Authors:  Gergely Imre; Verena Krähling; Madeleine Eichler; Sandra Trautmann; Nerea Ferreirós; M Javad Aman; Fatah Kashanchi; Krishnaraj Rajalingam; Stefan Pöhlmann; Stephan Becker; Dagmar Meyer Zu Heringdorf; Josef Pfeilschifter
Journal:  iScience       Date:  2021-03-05

6.  Remdesivir is efficacious in rhesus monkeys exposed to aerosolized Ebola virus.

Authors:  Travis K Warren; Christopher D Kane; Jay Wells; Kelly S Stuthman; Sean A Van Tongeren; Nicole L Garza; Ginger Donnelly; Jesse Steffens; Laura Gomba; Jessica M Weidner; Sarah Norris; Xiankun Zeng; Roy Bannister; Tomas Cihlar; Sina Bavari; Danielle P Porter; Patrick L Iversen
Journal:  Sci Rep       Date:  2021-09-30       Impact factor: 4.996

Review 7.  Application of Viral Vectors for Vaccine Development with a Special Emphasis on COVID-19.

Authors:  Kenneth Lundstrom
Journal:  Viruses       Date:  2020-11-18       Impact factor: 5.048

Review 8.  Harnessing Recent Advances in Synthetic DNA and Electroporation Technologies for Rapid Vaccine Development Against COVID-19 and Other Emerging Infectious Diseases.

Authors:  Ziyang Xu; Ami Patel; Nicholas J Tursi; Xizhou Zhu; Kar Muthumani; Daniel W Kulp; David B Weiner
Journal:  Front Med Technol       Date:  2020-10-21

Review 9.  Development and Structural Analysis of Antibody Therapeutics for Filoviruses.

Authors:  Xiaoying Yu; Erica Ollmann Saphire
Journal:  Pathogens       Date:  2022-03-18

Review 10.  Immunopathogenesis of Different Emerging Viral Infections: Evasion, Fatal Mechanism, and Prevention.

Authors:  Betsy Yang; Kuender D Yang
Journal:  Front Immunol       Date:  2021-07-15       Impact factor: 7.561
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.